105PPrognostic factors in crizotinib (CRZ)-resistant anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC) patients (Pts)Karen L. Reckamp,J. Lee, J. Huang,I. Proskorovsky,William Reichmann, M. Krotneva,David Kerstein,H. HuangAnnals of Oncology（2017）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
